Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Activation of liver X receptor inhibits osteopontin and ameliorates diabetic nephropathy.

Tachibana H, Ogawa D, Matsushita Y, Bruemmer D, Wada J, Teshigawara S, Eguchi J, Sato-Horiguchi C, Uchida HA, Shikata K, Makino H. Activation of liver X receptor inhibits osteopontin and ameliorates diabetic nephropathy. J Am Soc Nephrol. 2012 Nov; 23(11):1835-46.

View in: PubMed

© 2021 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.